Cargando…

Thromboembolic events following mRNA vaccines for COVID 19: a case series

Detalles Bibliográficos
Autores principales:	Serrao, Alessandra, Agrippino, Roberta, Brescini, Mattia, Mormile, Rosaria, Chistolini, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812355/ https://www.ncbi.nlm.nih.gov/pubmed/35118582 http://dx.doi.org/10.1007/s11239-021-02627-9

Ejemplares similares

Painless thyroiditis following mRNA vaccination for COVID-19
por: Nakaizumi, Nobuhiko, et al.
Publicado: (2022)

Panuveitis following mRNA-based COVID-19 vaccine
por: Bouayad, A., et al.
Publicado: (2023)

No evidence of an increased risk for cardiac complications following mRNA COVID-19 vaccines
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2023)

No evidence of an increased risk for cardiac complications following mRNA COVID-19 vaccines
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2023)

Membranous nephropathy following anti–COVID-19 mRNA vaccination
por: Gueguen, Lorraine, et al.
Publicado: (2021)

Ramsay Hunt syndrome following mRNA SARS-COV-2 vaccine()
por: Rodríguez-Martín, Minerva, et al.
Publicado: (2022)

Adult-onset Still's disease following mRNA COVID-19 vaccination
por: Sharabi, Amir, et al.
Publicado: (2021)

Parsonage Turner Syndrome Following Vaccination With mRNA-1273 SARS-CoV-2 Vaccine
por: Bernheimer, James H., et al.
Publicado: (2022)

Vascular thromboembolic events following COVID‐19 hospital discharge: Incidence and risk factors
por: Spyropoulos, Alex C., et al.
Publicado: (2021)

Venous Thromboembolism following Two Doses of COVID-19 mRNA Vaccines in the US Population, 2020–2022
por: Lai, Daoyuan, et al.
Publicado: (2022)

No apparent association between mRNA COVID-19 vaccination and venous thromboembolism
por: Nicholson, Matthew, et al.
Publicado: (2022)

Acute pericarditis following mRNA COVID-19 vaccination: An unforeseen event
por: Mashood, Faiz, et al.
Publicado: (2022)

Myocarditis and COVID-19 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Immune thrombocytopenia following COVID-19 mRNA vaccine: casuality or causality?
por: Pasin, Federico, et al.
Publicado: (2021)

Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine
por: Masset, Christophe, et al.
Publicado: (2021)

Scleroderma renal crisis following mRNA vaccination against SARS-CoV-2
por: Oniszczuk, Julie, et al.
Publicado: (2021)

Acute gastric and non-mesenteric colonic infarction following mRNA COVID-19 vaccination
por: Lee, Taek-Gu, et al.
Publicado: (2022)

Minimal change disease relapse following SARS-CoV-2 mRNA vaccine
por: Kervella, Delphine, et al.
Publicado: (2021)

Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study
por: Chui, Celine Sze Ling, et al.
Publicado: (2022)

Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine
por: de Nattes, Tristan, et al.
Publicado: (2022)

Myocarditis following COVID-19 mRNA vaccinations: Twin and sibling case series
por: Shenton, P., et al.
Publicado: (2023)

COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
por: Chen, Yu-Wei, et al.
Publicado: (2021)

Basophil activation tests with cryopreserved mRNA-based COVID-19 vaccines
por: Alcaraz-Serna, Ana, et al.
Publicado: (2023)

Corticosteroids and mRNA Vaccines: A Word of Caution
por: Zhong, Zifu, et al.
Publicado: (2021)

Myocarditis, pericarditis, and COVID-19 mRNA-vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Guillain–Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report
por: Masuccio, Fabio Giuseppe, et al.
Publicado: (2021)

Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine
por: Holzworth, Amy, et al.
Publicado: (2021)

Development of Venous Thromboembolism After COVID-19 mRNA-1273 Vaccine Inoculation
por: Mahgoub, Abdullahi E, et al.
Publicado: (2022)

COVID-19 thromboembolism is reduced in ambulatory, but not hospitalized patients, following COVID-19 vaccination
por: Stevens, Hannah, et al.
Publicado: (2023)

High Basal Maximal Standardized Uptake Value (SUV(max)) in Follicular Lymphoma Identifies Patients with a Low Risk of Long-Term Relapse
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2021)

A case of membranous nephropathy following Pfizer–BioNTech mRNA vaccination against COVID-19
por: Da, Yi, et al.
Publicado: (2021)

Letter regarding “Minimal change disease relapse following SARS-CoV-2 mRNA vaccine”
por: Schwotzer, Nora, et al.
Publicado: (2021)

Retinal Vascular Events after mRNA and Adenoviral-Vectored COVID-19 Vaccines—A Case Series
por: Girbardt, Christian, et al.
Publicado: (2021)

Passive inhaled mRNA vaccination for SARS-Cov-2
por: Yeo, Wee Song, et al.
Publicado: (2021)

Temporal metabolic response and mRNA COVID-19 vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis
por: Faissner, Simon, et al.
Publicado: (2021)

Effectiveness of mRNA Covid-19 vaccine in healthcare workers
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Effectiveness of mRNA Covid-19 vaccine in healthcare workers
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

COVID-19 mRNA vaccination in patients with previous myocarditis
por: Pieroni, Maurizio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n60b7ggo0636i88gb8jjghdf5t